Treatment and outcomes of recurrent hepatocellular carcinomas
- 11 May 2017
- journal article
- research article
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 402 (5) , 737-744
Abstract
Surgery is one of the best options for curative treatment of hepatocellular carcinomas (HCC). Recurrences are nevertheless common (45–75%). This study aimed to compare overall survival (OS) of patients with recurrent HCC after primary resection to OS of patients without recurrence.Keywords
This publication has 39 references indexed in Scilit:
- The Feasibility of Third or More Repeat Hepatectomy for Recurrent Hepatocellular CarcinomaAnnals of Surgery, 2015
- Recurrence of Hepatocellular Cancer After ResectionAnnals of Surgery, 2015
- Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasionJournal of Gastroenterology and Hepatology, 2014
- Transarterial chemoembolization for intrahepatic multiple recurrent HCC after liver resection or transplantationAnnals of Transplantation, 2014
- Hepatocellular carcinoma review: Current treatment, and evidence-based medicineWorld Journal of Gastroenterology, 2014
- Hepatocellular CarcinomaNew England Journal of Medicine, 2011
- Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experienceLiver Transplantation, 2011
- Recurrence after liver resection for hepatocellular carcinoma: Risk factors, treatment, and outcomesSurgery, 2007
- Factors Associated with Early Recurrence after Resection for Hepatocellular Carcinoma and OutcomesJournal of the American College of Surgeons, 2006
- Classification of Surgical ComplicationsAnnals of Surgery, 2004